Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 1973Annals of Internal Medicine

Propranolol

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

HMHoward F. MorrelliUnited States Department of Veterans Affairs

Discussion

Loading...

Member takes

Implication

Package inserts may omit evidence-based indications for propranolol; this leaves open questions on optimal clinician information sources.

Structured PICO

I
Intervention
Propranolol

The package insert for propranolol is inadequate as the sole source of drug information, as it fails to list several evidence-based uses such as hypertension and angina pectoris.

Cite This Study

Howard F. Morrelli (1973) studied this question.

synapsesocial.com/papers/6a71e22b2163a0a01bc5d426https://doi.org/10.7326/0003-4819-78-6-913

Topics

Hypertension managementHypertrophic cardiomyopathy
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1REDUCTION IN THE RISE OF SYSTOLIC BLOOD PRESSURE DURING HUMAN COITUS BY THE β-ADRENERGIC BLOCKING AGENT, PROPRANOLOL1970 · 19 citations
  2. 2Double-blind Trail to Propranolol (Inderal) in Angina Pectoris1965 · 104 citations
  3. 3Treatment of Hypertension with Propranolol1969 · 427 citations
  4. 4Effects of Propranolol and Isosorbide Dinitrate on Exercise Performance and Adrenergic Activity in Patients with Angina Pectoris1969 · 139 citations
  5. 5Propranolol in Patients with Angina Pectoris1967 · 111 citations